Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 21 Oct 2013 for SAVIENT PHARMACEUTICALS INC, €473.
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Ginger Constantine: trading record in brief
Ginger Constantine discloses dealings in Savient Pharmaceuticals Inc to SEC (Form 4). Between 8 June 2010 and 16 October 2013, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 1 sale worth €473. Other entries cover 3 share grants. So far in 2013, the count stands at no purchases and 1 sale.
The latest filing, published on 21 October 2013, reports an open-market sale of €473 in Savient Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ginger Constantine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
8,805 shares@ US$0.0726Common StockSEC:0001181431-13-054639:0
3,514 shares@ US$11.38Common Stock, $.01 par value per shareSEC:0001181431-10-032468:0
2 of 2 declarations
